From bench to drug: Human seizure modeling using Drosophila

Progress in Neurobiology

Volumn 84, Issue 2, 2008, Pages 182-191

  Song, Juan ^a,b   Tanouye, Mark A ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anticonvulsant drug development; Drosophila model; Epilepsy; Seizure suppressor; Topoisomerase I inhibitors

Indexed keywords

ANTICONVULSIVE AGENT; CAMPTOTHECIN; CARBAMAZEPINE; CARBENOXOLONE; DNA TOPOISOMERASE; DNA TOPOISOMERASE INHIBITOR; ETHOSUXIMIDE; GABAPENTIN; PHENYTOIN; POTASSIUM BROMIDE; SODIUM CHANNEL; VALPROIC ACID; VIGABATRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DISEASE PREDISPOSITION; DROSOPHILA; EPILEPSY; EPILEPTOGENESIS; GAP JUNCTION; GENE; GENE IDENTIFICATION; GENE MUTATION; HEREDITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVIEW; SEIZURE; SEIZURE REPRESSOR GENE;

ANIMALS; DISEASE MODELS, ANIMAL; DNA TOPOISOMERASES, TYPE I; DROSOPHILA; EPILEPSY; HUMANS; MUTATION;

EID: 38649111614     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2007.10.006     Document Type: Review

References (78)

1. Avoli M. Feline generalized penicillin epilepsy. Ital. J. Neurol. Sci. 16 (1995) 79-82
2. Baraban S.C. Emerging epilepsy models: insights from mice, flies, worms, and fish. Curr. Opin. Neurol. 20 (2007) 164-168
3. Baraban S.C., Taylor M.R., Castro P.A., and Baier H. Pentylenetetrazole induced changes in zebrafish behavior, neural activity and c-fos expression. Neuroscience 131 (2005) 759-768
4. Baraban S.C., Dinday M.T., Castro P.A., Chege S., Guyenet S., and Taylor M.R. A large-scale mutagenesis screen to identify seizure-resistant zebrafish. Epilepsia 48 (2007) 1151-1157
5. Batini C., Teillet M.A., and Naquet R. An avian model of genetic reflex epilepsy. Arch. Ital. Biol. 142 (2004) 297-312
6. Benzer S. From the gene to behavior. J. Am. Med. Assoc. 218 (1971) 1015-1022
7. Bertorelli R., Adami M., and Ongini E. The Mongolian gerbil in experimental epilepsy. Ital. J. Neurol. Sci 16 (1995) 101-106
8. Bier E. Drosophila, the golden bug, emerges as a tool for human genetics. Nat. Rev. Genet. 6 (2005) 9-23
9. Bier E., and Bodmer R. Drosophila, an emerging model for cardiac disease. Gene 342 (2004) 1-11
10. Boege F., Straub T., Kehr A., Boesenberg C., Christiansen K., Anderson A., Jacob F., and Kohrle J. Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I. J. Biol. Chem. 271 (1996) 2262-2270
11. Carlen P.L., Frances S., Zhang L., Naus C., Kushnir M., and Velazquez J.L. The role of gap junctions in seizures. Brain Res. Brain Res. Rev. 32 (2000) 235-241
12. Catterall W.A. Molecular properties of brain sodium channels: an important target for anticonvulsant drugs. Adv. Neurol. 79 (1999) 441-456
13. Champoux J.J. DNA topoisomerases: structure, function and mechanism. Annu. Rev. Biochem. 70 (2001) 369-413
14. Engel J.E., and Wu C.F. Altered mechanoreceptor response in Drosophila bang-sensitive mutants. J. Comp. Physiol. A 175 (1994) 267-278
15. Fergestad T., Bostwick B., and Ganetzky B. Metabolic disruption in Drosophila bang-sensitive seizure mutants. Genetics 173 (2006) 1357-1364
16. Gajda Z., Gyengesi E., Hermesz E., Ali K.S., and Szente M. Involvement of gap junctions in the manifestation and control of the duration of seizures in rats in vivo. Epilepsia 44 (2003) 1596-1600
17. Ganetzky B., and Wu C.-F. Indirect suppression involving behavioral mutants with altered nerve excitability in Drosophila melanogaster. Genetics 100 (1982) 597-614
18. Glasscock E., and Tanouye M.A. Drosophila couch potato mutants exhibit complex neurological abnormalities including epilepsy phenotypes. Genetics 169 (2005) 2137-2149
19. Glasscock E., Singhania A., and Tanouye M.A. The mei-P26 gene encodes a RING finger B-box coiled-coil-NHL protein that regulates seizure susceptibility in Drosophilia. Genetics 170 (2005) 1677-1689
20. Hekmat-Scafe D.S., Dang K.N., and Tanouye M.A. Seizure suppression by gain-of-function escargot mutations. Genetics 169 (2005) 1477-1493
21. - cotransporter gene kazachoc (kcc) increase seizure susceptibility in Drosophila. J. Neurosci. 26 (2006) 8943-8954
22. Jahromi S.S., Wentlandt K., Piran S., and Carlen P. Anticonvulsant actions of gap junctional blockers in an in vitro seizure model. J. Neurophysiol. 88 (2002) 1893-1902
23. Krishnan S.N., Frei E., Swain G., and Wyman R.J. Passover, a gene required for synaptic connectivity in the giant fiber system of Drosophila. Cell 73 (1993) 967-977
24. Kuebler D., and Tanouye M.A. Modifications of seizure susceptibility in Drosophila. J. Neurophysiol. 83 (2000) 998-1009
25. Kuebler D., and Tanouye M.A. Anticonvulsant valproate reduces seizure-susceptibility in mutant Drosophila. Brain Res. 958 (2002) 36-42
26. Kuebler D., Zhang H.G., Ren X., and Tanouye M.A. Genetic suppression of seizure susceptibility in Drosophila. J. Neurophysiol. 86 (2001) 1211-1225
27. Kuo C.C. A common anticonvulsant binding site for phenytoin, carbamazepine, and lamotrigine in neuronal sodium channels. Mol. Pharmacol. 54 (1998) 712-721
28. Kuroda M.I., Kernan M.J., Kreber R., Ganetzky B., and Baker B.S. The maleless protein associates with the X chromosome to regulate dosage compensation in Drosophila. Cell 66 (1991) 935-947
29. Lee J., and Wu C.-F. Electroconvulsive seizure behavior in Drosophila: analysis of the physiological repertoire underlying a stereotyped action pattern in bang-sensitive mutants. J. Neurosci. 22 (2002) 11065-11079
30. Lee M.P., Brown S.D., Chen A., and Hsieh T.-S. DNA topoisomerase I is essential in Drosophila melanogaster. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 6656-6660
31. Legare M.E., Bartlett II F.S., and Frankel W.N. A major effect QTL determined by multiple genes in epileptic EL mice. Genome Res. 10 (2000) 42-48
32. Leppard J.B., and Champoux J.J. Human DNA topoisomerase I: relaxation, roles, and damage control. Chromosoma 114 (2005) 75-85
33. Li T., and Liu L. Tumor cell death induced by topoisomerase-targeting drugs. Annu. Rev. Pharmacol. Toxicol. 41 (2000) 53-77
34. Lock C.J., Williams S.N., Schwarz E.M., Caldwell G.A., and Caldwell K.A. Genetic interactions among cortical malformation genes that influence susceptibility to convulsions in C. elegans (2006)
35. Lohi H., Young E.J., Fitzmaurice S.N., Rusbridge C., Chan E.M., Vervoort M., Turnbull J., Zhao X.C., Ianzano L., Paterson A.D., Sutter N.B., Ostrander E.A., André C., Shelton G.D., Ackerley C.A., Scherer S.W., and Minassian B.A. Expanded repeat in canine epilepsy. Science 307 (2005) 81
36. Loughney K., Kreber R., and Ganetzky B. Molecular analysis of the para locus, a sodium channel gene in Drosophila. Cell 58 (1989) 1143-1154
37. Mathijssen R.H., Loos W.J., Verweij J., and Sparreboom A. Pharmacology of topoisomerase I inhibitors irinotecan (CPT-11) and topotecan. Curr. Cancer Drug Targets 2 (2002) 103-123
38. McLean M.J., and MacDonald R.L. Multiple actions of phenytoin on mouse spinal cord neurons in cell culture. J. Pharmacol. Exp. Ther. 227 (1983) 779-789
39. McLean M.J., and MacDonald R.L. Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J. Pharmacol. Exp. Ther. 237 (1986) 1001-1011
40. McNamara J.O. Emerging insights into the genesis of epilepsy. Nature 399 Suppl. (1999) A15-A22
41. Menini C., and Silva-Barrat C. The photosensitive epilepsy of the baboon. A model of generalized reflex epilepsy. Adv. Neurol. 75 (1998) 29-47
42. Michno K., van de Hoef D., Wu H., and Boulianne G.L. Modeling age-related diseases in Drosophila: can this fly?. Curr. Top. Dev. Biol. 71 (2005) 199-223
43. Nelson J.C., and Wyman R.J. Examination of paralysis in Drosophila temperature-sensitive paralytic mutations affecting sodium channels; a proposed mechanism of paralysis. J. Neurobiol. 21 (1990) 453-469
44. Noebels J.L. The biology of epilepsy genes. Annu. Rev. Neurosci. 26 (2003) 599-625
45. Pascual A., Chaminade M., and Preat T. Ethanolamine kinase controls neuroblast divisions in Drosophila mushroom bodies. Dev. Biol. 280 (2005) 177-186
46. Pavlidis P., and Tanouye M.A. Seizures and failures in the giant fiber pathway of Drosophila bang-sensitive paralytic mutants. J. Neurosci. 15 (1995) 5810-5819
47. Pavlidis P., Ramaswami M., and Tanouye M.A. The Drosophila easily shocked gene: a mutation in a phospholipid synthetic pathway causes seizure, neuronal failure, and paralysis. Cell 79 (1994) 23-33
48. Phelan P., Nakagawa M., Wilkin M.B., Moffat K.G., O'Kane C.J., Davies J.A., and Bacon J.P. Mutations in shaking-B prevent electrical synapse formation in the Drosophila giant fiber system. J. Neurosci. 16 (1996) 1101-1113
49. Phelan P., and Starich T.A. Innexins get into the gap. Bioessays 23 (2001) 388-396
50. Pommier Y., Pourquier P., Fan Y., and Strumberg D. Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme. Biochim. Biophys. Acta 1400 (1998) 83-105
51. Pommier Y., Pourquier P., Urasaki Y., Wu J., and Laco G.S. Topoisomerase I inhibitors: selectivity and cellular resistance. Drug Resist. Updat. 2 (1999) 307-318
52. Purnam R.S., and McNamara J.O. Seizure disorders in mutant mice: relevance to human epilepsies. Curr. Opin. Neurobiol. 9 (1999) 281-287
53. Ragsdale D.S., and Avoli M. Sodium channels as molecular targets for antiepileptic drugs. Brain Res. Brain Res. Rev. 26 (1998) 16-28
54. Ramaswami M., and Tanouye M.A. Two sodium channel genes in Drosophila: implications for channel diversity. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 2079-2082
55. Reynolds E.R., Stauffer E.A., Feeney L., Rojahn E., Jacobs B., and McKeever C. Treatment with the antiepileptic drugs phenytoin and gabapentin ameliorates seizure and paralysis of Drosophila bang-sensitive mutants. J. Neurobiol. 58 (2003) 503-513
56. Royden C.S., Pirrotta V., and Jan L.Y. The tko locus, site of a behavioral mutation in D. melanogaster, codes for a protein homologous to prokaryotic ribosomal protein S12. Cell 51 (1987) 165-173
57. Rubin G.M., and Lewis E.B. A brief history of Drosophila's contributions to genome research. Science 287 (2000) 2216-2218
58. Snyder R.D., and Gillies P.J. Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells. Environ. Mol. Mutagen. 40 (2002) 266-276
59. 2, a gap junction mutation in Drosophila. J. Neurophysiol. 95 (2006) 627-635
60. Song J., and Tanouye M. A role for para sodium channel gene 3′ UTR in the modification of Drosophila seizure susceptibility. Dev. Neurobiol. 67 (2007) 1944-1956
61. Song J., Hu J., and Tanouye M. Seizure suppression by top1 mutations in Drosophila. J. Neurosci. 27 (2007) 2927-2937
62. Stilwell G.E., Saraswati S., Littleton J.T., and Chouinard S.W. Development of a Drosophila seizure model for in vivo high-throughput drug screening. Eur. J. Neurosci. 24 (2006) 2211-2222
63. Szente M., Gajda Z., Said Ali K., and Hermesz E. Involvement of electrical coupling in the in vivo ictal epileptiform activity induced by 4-aminopyridine in the neocortex. Neuroscience 115 (2002) 1067-1078
64. Tan J.S., Lin F., and Tanouye M.A. Potassium bromide, an anticonvulsant, is effective at alleviating seizures in the Drosophila bang-sensitive mutant bang senseless. Brain Res. 1020 (2004) 45-52
65. Thomas J.B., and Wyman R.J. Mutations altering synaptic connectivity between identified neurons in Drosophila melanogaster. J. Neurosci. 4 (1984) 530-538
66. Tickoo S., and Russell S. Drosophila melanogaster as a model system for drug discovery, and pathway screening. Curr. Opin. Pharmacol. 2 (2002) 555-560
67. Tornberg J., Voikar V., Savilahti H., Rauvala H., and Airaksinen M.S. Behavioural phenotypes of hypomorphic KCC2-deficient mice. Eur. J. Neurosci. 21 (2005) 1327-1337
68. Veraksa A., Del Campo M., and McGinnis W. Developmental patterning genes, and their conserved functions: from model organisms to humans. Mol. Genet. Metab. 69 (2000) 85-100
69. Vidal M., and Cagan R.L. Drosophila models for cancer research. Curr. Opin. Genet. Dev. 16 (2006) 10-16
70. Wang H.-K., Morris-Natschke S.L., and Lee K.-H. Recent advances in discovery and development of topoisomerase inhibitors as antitumor agents. Med. Res. Rev. 17 (1997) 367-425
71. White S.H., Woodhead J.H., Wilcox K.S., Kupferberg H.J., and Wolf H.H. Discovery and preclinical development of anitepileptic drugs. In: Levy R.H., Mattson R.H., Meldrum B.S., and Perucca E. (Eds). Antiepileptic Drugs (2002), Lippincott Williams & Wilkins 36-48
72. Williams S.N., Locke C.J., Braden A.L., Caldwell K.A., and Caldwell G.A. Epileptic-like convulsions associated with LIS-1 in the cytoskeletal control of neurotransmitter signaling in Caenorhabditis elegans. Hum. Mol. Genet. 13 (2004) 2043-2059
73. Woo N.-S., Lu J., England R., McClellan R., Dufour S., Mount D.B., Deutch A.Y., Lovinger D.M., and Delpire E. Hyperexcitability and epilepsy associated with disruption of the mouse neuronal-specific K-Cl cotransporter gene. Hippocampus 12 (2002) 258-268
74. Yang Y., and Frankel W.N. Genetic approaches to studying mouse models of human seizure disorders. Adv. Exp. Med. Biol. 548 (2004) 1-11
75. Zhang Y.Q., Roote J., Brogna S., Davis A.W., Barbash D.A., Nash D., and Ashburner M. Stress sensitive B encodes an adenine nucleotide translocase in Drosophila melanogaster. Genetics 153 (1999) 891-903
76. Zhang Z., Curtin K.D., Sun Y.A., and Wyman R.J. Nested transcripts of gap junction gene have distinct expression patterns. J. Neurobiol. 40 (1999) 288-301
77. Zhang C.X., Chen A.D., Gettel N.J., and Hsieh T.-S. Essential functions of DNA Topoisomerase I in Drosophila melanogaster. Dev. Biol. 222 (2000) 27-40
78. Zhang H.G., Tan J., Reynolds E., Kuebler D., Faulhaber S., and Tanouye M.A. The Drosophila slamdance gene: a mutation in an aminopeptidase can cause seizure, paralysis and neuronal failure. Genetics 162 (2002) 1283-1299